Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

271

Participants

Timeline

Start Date

March 10, 2005

Primary Completion Date

December 12, 2007

Study Completion Date

December 12, 2007

Conditions
Anovulation
Interventions
DRUG

Anastrozole 1 mg

Subjects will be administered orally with 1 mg of anastrozole once daily for 5 days in Cycle 1, 2 and 3 (each cycle = approximately 1 month).

DRUG

Anastrozole 5 mg

Subjects will be administered orally with 5 mg of anastrozole once daily for 5 days in Cycle 1, 2 and 3 (each cycle = approximately 1 month).

DRUG

Anastrozole 10 mg

Subjects will be administered orally with 10 mg of anastrozole once daily for 5 days in Cycle 1, 2 and 3 (each cycle = approximately 1 month).

DRUG

Clomiphene Citrate 50 mg

Subjects will be administered orally with 50 mg of clomiphene citrate once daily for 5 days in Cycle 1, 2 and 3 (each cycle = approximately 1 month).

DRUG

Clomiphene Citrate 100 mg

Subjects will be administered orally with 100 mg of clomiphene citrate once daily for 5 days in Cycle 2 and 3 (each cycle = approximately 1 month).

Trial Locations (1)

02370

Local US Medical Information, Rockland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT00213148 - Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction | Biotech Hunter | Biotech Hunter